InnaMed

📍 Philadelphia, United States🗓 Founded 2016👥 3 employees💰 Last funded 2021
Biotechnology
LinkedIn
InnaMeds HomeLab device and software let patients access precision medical care from the comfort and privacy of their own home. Healthcare providers and researchers can receive timely clinical reports that they are accustomed to interpreting directly to their EMR, LIMS or EDC system. Pattern identification and conditional workflows guide decision making in the prescription and dosing of therapy and deep integration with the healthcare system and telehealth services allows for data driven care while also ensuring human connection. Currently looking to collaborate with CROs and pharmaceutical companies to enable custom research and commercial solutions. Soon will be offering chronic care providers a clinically robust platform for remote patient monitoring.
2
Total investors
0
Early stage
2
Mid stage
0
Late stage
2016
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Italy
1
Germany
1
Frequently asked questions
Who invested in InnaMed?
InnaMed has 2 investors on record on gritt.io, 2 mid-stage.
When did InnaMed last raise funding?
The most recent investment in InnaMed recorded on gritt.io was in 2021.
When was InnaMed founded?
InnaMed was founded in 2016.
What industry is InnaMed in?
InnaMed operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is InnaMed based?
InnaMed is headquartered in Philadelphia, United States.